163 related articles for article (PubMed ID: 21185786)
1. High level of soluble HLA-G in amniotic fluid is correlated with congenital transmission of Toxoplasma gondii.
Robert-Gangneux F; Gangneux JP; Vu N; Jaillard S; Guiguen C; Amiot L
Clin Immunol; 2011 Feb; 138(2):129-34. PubMed ID: 21185786
[TBL] [Abstract][Full Text] [Related]
2. Soluble human leukocyte antigen-G isoforms in maternal plasma in early and late pregnancy.
Rizzo R; Andersen AS; Lassen MR; Sørensen HC; Bergholt T; Larsen MH; Melchiorri L; Stignani M; Baricordi OR; Hviid TV
Am J Reprod Immunol; 2009 Nov; 62(5):320-38. PubMed ID: 19811467
[TBL] [Abstract][Full Text] [Related]
3. HLA-G antigen and parturition: maternal serum, fetal serum and amniotic fluid levels during pregnancy.
Hackmon R; Hallak M; Krup M; Weitzman D; Sheiner E; Kaplan B; Weinstein Y
Fetal Diagn Ther; 2004; 19(5):404-9. PubMed ID: 15305096
[TBL] [Abstract][Full Text] [Related]
4. Detection of soluble HLA-G molecules in plasma and amniotic fluid.
Rebmann V; Pfeiffer K; Pässler M; Ferrone S; Maier S; Weiss E; Grosse-Wilde H
Tissue Antigens; 1999 Jan; 53(1):14-22. PubMed ID: 10082427
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of quantitative polymerase chain reaction in amniotic fluid as early prognostic marker of fetal infection with Toxoplasma gondii.
Romand S; Chosson M; Franck J; Wallon M; Kieffer F; Kaiser K; Dumon H; Peyron F; Thulliez P; Picot S
Am J Obstet Gynecol; 2004 Mar; 190(3):797-802. PubMed ID: 15042017
[TBL] [Abstract][Full Text] [Related]
6. [Detection of congenital toxoplasmosis in utero with a polymerase chain reaction on amniotic fluid].
Gołab E; Nowakowska D; Waloch M; Dzbeński TH; Szaflik K; Wilczyński J
Wiad Parazytol; 2002; 48(3):311-5. PubMed ID: 16888977
[TBL] [Abstract][Full Text] [Related]
7. Prenatal diagnosis of congenital toxoplasmosis.
Antsaklis A; Daskalakis G; Papantoniou N; Mentis A; Michalas S
Prenat Diagn; 2002 Dec; 22(12):1107-11. PubMed ID: 12454967
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis of congenital Toxoplasma gondii infection by polymerase chain reaction (PCR) on amniotic fluid samples. The Norwegian experience.
Jenum PA; Holberg-Petersen M; Melby KK; Stray-Pedersen B
APMIS; 1998 Jul; 106(7):680-6. PubMed ID: 9740505
[TBL] [Abstract][Full Text] [Related]
9. Management of Toxoplasma gondii infection during pregnancy.
Montoya JG; Remington JS
Clin Infect Dis; 2008 Aug; 47(4):554-66. PubMed ID: 18624630
[TBL] [Abstract][Full Text] [Related]
10. [The Role of Soluble HLA-G in the Vertical Transmission of Toxoplasma gondii].
Wang HF; Jiang YZ; Ren LQ; Liu XB; Zhang HX; Hu XM
Mol Biol (Mosk); 2019; 53(2):303-310. PubMed ID: 31099780
[TBL] [Abstract][Full Text] [Related]
11. [Prenatal diagnostics of Toxoplasma gondii invasion by quantitative method of PCR-TaqMann].
Czuba B; Pendzich J; Gola J; Mazurek U; Sławska H; Kamiński K; Wilczok T
Wiad Parazytol; 2001; 47 Suppl 1():91-7. PubMed ID: 16897958
[TBL] [Abstract][Full Text] [Related]
12. Congenital toxoplasmosis after a preconceptional or periconceptional maternal infection.
Robert-Gangneux F; Yera H; D'Herve D; Guiguen C
Pediatr Infect Dis J; 2009 Jul; 28(7):660-1. PubMed ID: 19561432
[TBL] [Abstract][Full Text] [Related]
13. Low levels of natural killer cells in pregnant women transmitting Toxoplasma gondii.
Nigro G; Piazze J; Paesano R; Mango T; Provvedi S; Capuano O; Pollastrini L
Prenat Diagn; 1999 May; 19(5):401-4. PubMed ID: 10360506
[TBL] [Abstract][Full Text] [Related]
14. Congenital toxoplasmosis--prenatal aspects of Toxoplasma gondii infection.
Rorman E; Zamir CS; Rilkis I; Ben-David H
Reprod Toxicol; 2006 May; 21(4):458-72. PubMed ID: 16311017
[TBL] [Abstract][Full Text] [Related]
15. Maternal antigen presenting cells are a source of plasmatic HLA-G during pregnancy: longitudinal study during pregnancy.
Alegre E; Díaz-Lagares A; Lemaoult J; López-Moratalla N; Carosella ED; González A
Hum Immunol; 2007 Aug; 68(8):661-7. PubMed ID: 17678720
[TBL] [Abstract][Full Text] [Related]
16. [Direct detection of Toxoplasma gondii with polymerase chain reaction in diagnosis of fetal toxoplasma infection].
Knerer B; Hayde M; Gratzl R; Strobl W; Pollak A
Wien Klin Wochenschr; 1995; 107(4):137-40. PubMed ID: 7709629
[TBL] [Abstract][Full Text] [Related]
17. Congenital toxoplasmosis.
Jones J; Lopez A; Wilson M
Am Fam Physician; 2003 May; 67(10):2131-8. PubMed ID: 12776962
[TBL] [Abstract][Full Text] [Related]
18. Soluble HLA-G: purification from eukaryotic transfected cells and detection by a specific ELISA.
Fournel S; Aguerre-Girr M; Campan A; Salauze L; Berrebi A; Lone YC; Lenfant F; Le Bouteiller P
Am J Reprod Immunol; 1999 Jul; 42(1):22-9. PubMed ID: 10429763
[TBL] [Abstract][Full Text] [Related]
19. [Detection of Toxoplasma gondii DNA by PCR in mother's blood, amniotic fluid and child's blood in selected cases of pathological pregnancy].
Sławska H; Pendzich J; Czuba B; Mazurek U; Gola J; Wilczok T; Kamiński K
Wiad Parazytol; 2001; 47 Suppl 1():99-105. PubMed ID: 16897959
[TBL] [Abstract][Full Text] [Related]
20. Congenital toxoplasmosis: the importance of the western blot method to avoid unnecessary therapy in potentially infected newborns.
Tridapalli E; Capretti M; Farneti G; Marangoni A; Cevenini R; Faldella G
Acta Paediatr; 2008 Sep; 97(9):1298-300. PubMed ID: 18616630
[No Abstract] [Full Text] [Related]
[Next] [New Search]
